Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
blue inspection is a Germany-based pharmaceutical quality and compliance services company focused on independent GxP audits across the drug supply chain. The company conducts GMP, GDP, and related supplier audits for active pharmaceutical ingredient manufacturers, excipient manufacturers, packaging material suppliers, contract manufacturers, laboratories, and distributors. It operates as an ISO 17020-accredited inspection body and emphasizes independence, regulatory-grade audit reports, and global audit execution. Rather than developing therapeutics, blue inspection supports pharmaceutical manufacturers and marketing authorization holders with supplier qualification, risk management, and compliance oversight.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on blue inspection GmbH.